Ozempic Lawsuit in Pennsylvania (GLP-1 Claims)

What Pennsylvania residents should know

Pennsylvania residents with GLP-1 injury claims are generally not limited to Pennsylvania state court. Most filed cases are transferred into the federal multidistrict litigation, MDL-3094, before Judge Karen S. Marston in the Eastern District of Pennsylvania, which held 3,763 pending cases as of June 1, 2026.

Pennsylvania law still matters: the state's filing deadline, damages rules, and procedural law can shape an individual claim even when the case is litigated in the MDL.

Possible eligibility factors

• Documented use of a GLP-1 medication (prescription and pharmacy records from Pennsylvania providers).
• A diagnosis such as gastroparesis, ileus, or bowel obstruction — commonly supported by a gastric emptying study, endoscopy, imaging, or hospitalization records.
• Injury timing consistent with medication use.
• Filing within the deadline that applies to the claim under Pennsylvania law.

How Pennsylvania claims proceed

Most Pennsylvania GLP-1 cases are filed in or transferred to MDL-3094 in the Eastern District of Pennsylvania for coordinated proceedings. The court has scheduled Rule 702 expert-admissibility hearings for September 10–18, 2026 (Case Management Order No. 32); bellwether trial dates have not yet been set. Pennsylvania's general personal injury limitations period is 2 years (42 Pa. Cons. Stat. § 5524), but accrual and discovery-rule questions are fact-specific for injuries that develop during ongoing medication use.

Records to gather

• Medical records related to diagnosis, treatment, and symptoms.
• Records showing use of, prescription for, or exposure to the product or substance involved.
• Pharmacy, clinic, employment, military, agricultural, or exposure records where relevant.
• Photos, receipts, dental invoices, pathology reports, or specialist records if applicable.

State-specific exposure and context

Pennsylvania residents may have been prescribed Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, Zepbound, or Trulicity through endocrinologists, primary care practices, weight-management clinics, telehealth services, or hospital systems across the state.

Where cases may be handled

Living in Pennsylvania does not necessarily mean the case will be filed only in Pennsylvania. Claims may be evaluated by national firms, filed in federal court, coordinated through MDL proceedings, or handled through another legal process.

Federal courts in Pennsylvania

• Eastern District of Pennsylvania
• Middle District of Pennsylvania
• Western District of Pennsylvania

How long do Pennsylvania residents have to file?

Pennsylvania's general personal injury statute of limitations is 2 years (42 Pa. Cons. Stat. § 5524). Product liability and toxic exposure claims do not always follow the general rule — accrual timing, tolling, and repose periods can change the real deadline in an individual case.

• General personal injury period: 2 years — 42 Pa. Cons. Stat. § 5524.
• Discovery rule: Pennsylvania applies a discovery rule that can delay accrual until the injury and its cause reasonably could have been discovered.

Because the controlling deadline depends on diagnosis date, discovery facts, exposure history, wrongful-death rules, and how the claim is filed, only a licensed attorney can confirm the deadline that applies to a specific situation. This page is general legal information, not legal advice.

Questions to ask a lawyer

• Are you currently reviewing Ozempic / GLP-1 claims?
• What records do you need to evaluate my claim?
• How do Pennsylvania filing deadlines affect my situation?
• Would my claim be handled locally, nationally, or through an MDL?
• Do you work directly on this case or refer it to another firm?
• Are there upfront costs?